查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1847185

美国介入性心臟病器材市场：市场规模、份额和趋势分析（2025-2031 年）

Interventional Cardiology Device Market Size, Share & Trends Analysis | United States | 2025-2031 | Includes: Coronary Stents Coronary Balloon Catheters Balloon-Inflation Devices, and 12 more
出版日期: | 出版商: iData Research Inc. | 英文 271 Pages | 商品交期: 最快1-2个工作天内

价格
如有价格方面的疑问请按下「询问」键来信查询

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024年美国介入性心臟病器材市场规模约44亿美元。预计在预测期内，该市场规模将超过56亿美元。

本报告对经皮冠状动脉介入治疗及相关诊断检查中使用的所有核心产品类别进行了规模和分析，包括冠状动脉支架、冠状动脉导管导引线导管、球囊扩张装置、介入冠状动脉导管、介入冠状动脉动脉粥状硬化斑块切除术、冠状动脉栓塞保护装置 (EPD)、冠状动脉斑块切除术和血管内碎石术 (IVL) 装置、导引鞘、冠状动脉完全超音波(CTO)系统、导管鞘、冠状动脉血管光同调断层扫瞄(VCD)、诊断性冠状动脉导管导引线和导引线、经皮血管内超音波 (IVUS)、冠状动脉光学相干断层扫描 (OCT) 和止血产品类型。

量化范围包括销量、平均售价、市值、成长率、企业市场占有率和手术例数。

定性内容包括市场驱动因素和限制因素、併购、投资组合更新以及医院和导管室的实际技术趋势。

市场概览

美国的介入性心臟病学正朝着数据引导、影像丰富和流程高效的方向发展。预计经皮冠状动脉介入治疗（PCI）的数量将以较低的个位数成长率成长，但设备需求不仅受数量驱动，也受产品组合的影响。

医生利用血管内超音波（IVUS）和光学相干断层扫描（OCT）来确定血管大小、表征斑块并优化支架植入。这种以影像为先导的方法正在影响病灶预备工具的选择，包括经皮冠状动脉介入治疗（PTCA）、特殊球囊、药物释放型支架以及用于钙化病变的斑块切除术和血管内激光消融术（动脉粥状硬化斑块切除术）。同时，医疗机构正面临人员短缺、价格压力和合约整合等问题。

这导致人们对捆绑式布置、标准化托盘、径向通道和闭合装置的兴趣日益浓厚，这些措施可以缩短恢復时间并加快房间週转速度。

在预测期内，影像技术将更深入地融入规划和决策中，而支架和球囊平台将继续改进输送性、外形和涂层技术，以应对更广泛的病变，并获得可预测的结果。

市场驱动因素

新技术的发展。包括CT、MRI、IVUS和OCT在内的先进心血管影像技术的应用，提高了病变检出率和手术方案製定的准确性。新一代药物释放型支架结构更加精密，药物涂层更薄，预计将提高疗效并扩大可治疗的病变类型。

研发投入庞大。患者群体不断成长，推动了各领域参与度的提升。激烈的竞争加速了导管导引线、微导管、球囊、动脉粥状硬化斑块切除术、血管内雷射消融术和封堵器等领域的创新，从而实现了更快、更微创的手术和更稳定的治疗效果。

糖尿病盛行率不断上升。到2021年，美国约有11%的人口患有糖尿病。这种疾病负担增加了冠状动脉疾病的盛行率，从而对经皮冠状动脉介入治疗（PCI）的需求持续增长，尤其是在伴随瀰漫性动脉粥状硬化和钙化的复杂病变中。

经皮冠状动脉介入治疗（PCI）手术量。预计PCI手术量将以较低的个位数成长率成长。即使手术量仅略有增长，也会增加对支架、球囊导管、介入导管、导管导引线以及每例手术中使用的相关设备的需求。

影像主导的优化。医疗机构投资于血管内超音波（IVUS）主机、光学相干断层扫描（OCT）平台和成像导管，以减少定位误差，优化支架扩张，并记录结果，供品质管理专案和支付方使用。

桡动脉入路与术后恢復。桡动脉入路的广泛应用有助于提高患者舒适度并缩短住院时间。这有利于使用导引器、桡动脉专用鞘套以及专为快速止血和早期下床活动而设计的血管闭合装置。

病变预备工具。对于复杂的钙化病变，可采用动脉粥状硬化斑块切除术或血管内震波碎石术来改善支架输送性能，确保支架完全扩张，从而降低血管再阻塞和再次手术的风险。

市场限制

外部市场短缺。技术纯熟劳工短缺对供应商和医疗服务提供者都造成了影响。生产延误、服务週期延长以及导管室人员短缺会降低吞吐量并加剧资本规划压力。这些压力也推动市场朝向自动化和精简产品选择方向发展。

捆绑销售和价格压力。大型竞争对手透过谈判达成涵盖支架、球囊、导管导引线、导管和椎体闭合装置等广泛产品的系统性合约。捆绑销售简化了采购流程，但也压缩了平均售价，给小型製造商带来了挑战。随着行业整合加剧，我们预计许多产品类别的价格将稳定下降。

冠状动脉疾病的替代治疗方法。除了经皮冠状动脉介入治疗（PCI）之外，患者和临床医生还在利用復健计画、药物优化和个人化自我管理。补充和替代疗法、自我检测以及药物技术的进步，在某些情况下可能会延缓甚至取代介入治疗，这限制了该手术的发展。

影像设备投资。 OCT 和 IVUS 需要前期投资购买主机，并需持续支付耗材费用。一些中心正在分阶段实施这些技术，同时评估其使用和报销模式。

供应链和监管摩擦：产品组合更新和合规措施可能会延长产品上市时间，并使库存更加复杂。

目标市场和数据范围

定量分析：市场规模、市场占有率、市场预测、成长率、销售量、平均售价和手术数量。

定性通报：成长驱动因素和限制因素、竞争分析、主要竞争对手的 SWOT 分析、併购、公司简介和产品系列、FDA 召回（如适用）、颠覆性技术、影响 PCI 治疗路径的疾病概况。

时限：基准年 2024 年，预测年 2025-2031 年，历史资料 2021-2024 年。

资料来源：对行业领袖和医生的直接访谈、政府医生和手术资料、监管资料库、私人医院资料、进出口资料、iData Research 内部资料库。

方法论收入模型为单位乘以平均售价，并根据 PCI 量、影像采用率、入院途径组合以及医院和综合医疗服务网路中的设施采购模式检验。

目标市场及区隔

冠状动脉支架市场

器械类型：裸金属支架、药物释放型支架、覆膜支架、分岔支架。

单年单位份额依尺寸细分：直径和长度。

冠状动脉球囊导管

器械类型： PTCA球囊扩张术，特殊球囊。

按类别分類的年度销售量份额：合规、半相容、不合规。

以适应症分類的单年销售份额。术前扩张和支架置入，术后扩张。

球囊扩张装置

冠状动脉导管

器械类型：引导管、扩张引导管、微导管。

冠状动脉导管导引线

冠状动脉栓塞保护装置（EPD）

冠状动脉动脉粥状硬化斑块切除术装置

设备类型：机械切除术、雷射切除术、血管内碎石术（IVL）。

冠状动脉血栓切除术

冠状动脉慢性完全阻塞（CTO）系统

器械类型： 导管导引线、CTO导管、CTO器械。

导引鞘

器械类型：标准导引器、导引器。

依入路：股骨、桡骨。

冠状动脉血管闭合装置（VCD）

侵入性VCD和非侵入性VCD。

诊断性冠状动脉导管和导管导引线

器械类型：诊断导管、诊断导管导引线、血流储备分数导管导引线。

冠状动脉血管内超音波（IVUS）

设备类型： IVUS导管，IVUS主机。

冠状动脉光同调断层扫瞄（OCT）

设备类型：OCT导管、OCT主机。

止血瓣

竞争分析

波士顿科学公司在冠状动脉支架、冠状动脉球囊导管和冠状动脉栓塞保护装置领域占据主导地位，并将成为 2024 年的主要竞争对手。随着新型冠状动脉药物涂层球囊的普及，预计其市场份额将稳定成长。

雅培拥有广泛的产品组合，并在各个细分市场中均名列前茅。雅培在OCT领域没有直接竞争对手，这巩固了其在影像主导PCI策略方面的领先地位。预计该公司将保持其整体市场份额。

排名第三的是ShockWave Medical公司，该公司专门从事血管内碎石术（IVL）。 IVL技术近年来才获得核准，但在治疗冠状动脉钙化斑块的应用持续快速成长。

其他参与企业在支架、球囊、导管导引线、导管、血管闭合装置（VCD）、血栓切除术和诊断影像学等领域竞争。竞争优势体现在产品组合的深度、桡动脉入路解决方案、在复杂解剖结构中的输送能力，以及将影​​像引导与病变准备和器械植入相结合的能力。

科技与临床趋势

影像学是手术的基础。血管内超音波（IVUS）和光学相干断层扫描（OCT）正从选用工具逐渐成为许多实验室的常规指导手段。医师依赖影像学评估斑块形态、钙化深度和支架扩张情况。高解析度CT在特定病例中可用于术前规划。

钙化管理。动脉粥状硬化斑块切除术和血管内震波碎石术（IVL）的发展反映了安全、可预测地治疗高度钙化病灶的需求。这些技术提高了支架完全扩张和获得持久疗效的可能性。

更聪明的球囊和支架。具有特定顺应性和改进外形的专用球囊，以及先进的药物释放型支架，有助于解决复杂的解剖结构和分叉问题，同时控製手术时间。

以桡动脉入路为主导的工作流程。医疗机构投资购买桡动脉导管导入器、微型导管导入器和血管闭合解决方案，以支持合适的患者早期下床活动和当日出院。

实验室效率。人员短缺迫使实验室将托盘标准化，优化充气装置，并选择能缩短恢復时间的闭合装置。影像优化还能减少重复操作，并支援以价值为导向的目标。

资料和文檔。成像系统和主机支援品质计划、同行评审和合约的案例文件记录，从而增强了采用该系统的必要性。

护理机构

本报告针对医院、综合医疗服务网络以及学术和区域性导管室。报告涵盖了直接采购、集团采购安排和供应商管理库存等采购模式。

设施类型会影响存取方式、影像实施和捆绑合约偏好。

Radial First 工厂将专注于导引器和闭合产品。

病例量大、病情复杂的中心往往会更快地投资于 IVUS 和 OCT，并拥有更广泛的动脉粥状动脉粥状硬化斑块切除术和 IVL 工具来进行钙化管理。

地区

本期重点关注美国。

本报告的目的

到 2031 年，美国介入性心臟病学器材市场中最大、成长最快的机会是什么？支架、球囊、斑块切除术、血管内雷射消融术 (IVL)、动脉粥状硬化斑块切除术(CTO) 系统、导管导引线、导管、心肺復苏术 (EPD)、血管闭合装置 (VCD)、血管内超音波 (IVUS) 和光学相干断层扫描 (OCT) 将各自如何创造价值？

介入性心臟病设备市场与美国整体经济和医院管理有何关係？包括人员配备限制、诊断影像的资本规划以及有利于捆绑销售和标准化的采购策略。

未来哪些因素会影响市场走向，例如血管内超音波 (IVUS) 和光学相干断层扫描 (OCT) 的发展、药物释放型支架的改进以及桡动脉入路和当日出院途径的普及？

哪一种显像模式最有利于日常诊疗中的最佳化？实验室应如何根据病例组合、报销情况和工作人员的熟悉程度来决定采用血管内超音波（IVUS）还是光学相干断层扫描（OCT）？

病变准备策略将如何发展？在治疗严重钙化时，动脉粥状硬化斑块切除术和血管内震波碎石术（IVL）的适当作用是什么，以确保完全扩张并减少血管再阻塞？

合规、半相容和不合规的设定檔会对交付率、安全性和一致性产生怎样的影响？

预计桡动脉入路和股动脉入路之间的平衡如何？这种选择将如何影响医院和导管室对导引鞘、导引器、闭合闭合装置、止血阀和附件包的需求？

具体而言，OCT 和 IVUS 在病变评估、支架尺寸确定和放置后优化、主机放置、一次性导管拉出以及培训需求方面的应用。

鑑于下一代药物释放型支架和药物涂层球囊的安全审查历史以及它们对更细支架、改性聚合物和可控药物输送的重视，它们将如何影响病例选择和定价？

对于钙化病变，血管内碎石术的现实轨迹是什么？在复杂的PCI手术中，血管内碎石术与动脉粥状硬化斑块切除术和高压非顺应性球囊的使用有何交互作用？

iData Research 的《美国介入性心臟病设备市场报告》透过细分和配置模型、企业市场占有率分析、定价详情以及将成像和接入选择与设备消费联繫起来的研究来回答这些问题。

利用这份报告，按类别拓展业务机会，规划产品蓝图，使合约和库存与医院需求保持一致，并设定培训和服务目标，以提高导管室的一致性。

目录

图表清单

图表列表

美国介入性心臟病器材市场概览

竞争分析

市场趋势

市场趋势

流程分段

待调查的程式码

市场区隔

重要报告更新

版本历史记录

调查方法

全球关税的影响

美国介入性心臟病器材市场概览

  • 介绍
    • 处于风险中的族群
  • 市场概况及趋势分析
  • 驾驶员和约束装置
  • 竞争市占率分析
  • 併购

手术次数

  • 介绍
  • 程式
    • 血管造影术
    • 血管成形术/经皮冠状动脉介入治疗
    • 冠状动脉切除术
    • 慢性完全冠状动脉阻塞手术
    • 导管插入术
    • 冠状动脉血管内超音波
    • 冠状动脉光学同调断层扫描
    • 血流储备分数导管导引线技术

冠状动脉支架市场

  • 介绍
  • 市场概览
  • 市场分析与预测
    • 冠状动脉支架市场整体状况
    • 裸金属支架市场
    • 药物释放型支架市场
    • 覆盖支架市场
    • 双支架市场
  • 单位数量分析
  • 驾驶员和约束装置
  • 竞争市占率分析

冠状动脉球囊导管市场

  • 介绍
  • 市场概览
  • 市场分析与预测
    • 冠状动脉球囊导管市场整体状况
    • Ptca气球市场
    • 气球专业市场
    • 冠状动脉球囊导管装置（依分类）
    • 冠状动脉球囊导管装置（依适应症）
  • 驾驶员和约束装置
  • 竞争市占率分析

气球充气装置市场

  • 介绍
  • 市场分析与预测
  • 驾驶员和约束装置
  • 竞争市占率分析

介入性冠状动脉导管市场

  • 介绍
  • 市场概览
  • 市场分析与预测
    • 介入性冠状动脉导管市场总规模
    • 导尿管市场指南
    • 延长引导管市场
    • 微导管市场
  • 驾驶员和约束装置
  • 竞争市占率分析

介入性冠状动脉导线市场

  • 介绍
    • 建构设备
  • 市场分析与预测
  • 驾驶员和约束装置
  • 竞争市占率分析

冠状动脉栓塞保护装置市场

  • 介绍
    • 大隐静脉移植
    • 保护机制
  • 市场分析与预测
  • 驾驶员和约束装置
  • 竞争市占率分析

冠状动脉粥样斑块切除器械市场

  • 介绍
    • 设备技术
  • 市场概览
  • 市场分析与预测
    • 全冠状动脉粥样斑块切除器械市场
    • 机械动脉切除术市场
    • 雷射动脉切除术市场
    • 血管内碎石市场
  • 驾驶员和约束装置
  • 竞争市占率分析

冠状动脉血栓切除术市场

  • 介绍
    • 药物释放型支架及血栓症治疗
  • 市场分析与预测
  • 驾驶员和约束装置
  • 竞争市占率分析

冠状动脉慢性完全阻塞系统市场

  • 介绍
  • 市场概览
  • 市场分析与预测
    • 冠状动脉慢性完全阻塞系统市场
    • Cto导管导引线市场
    • CTO导管市场
    • CTO设备市场
  • 驾驶员和约束装置
  • 竞争市占率分析

导引鞘市场

  • 介绍
  • 市场概览
  • 市场分析与预测
    • 导引鞘市场
    • 标准导引鞘市场
    • 导引鞘市场
  • 方法导引鞘单元
  • 驾驶员和约束装置
  • 竞争市占率分析

冠状动脉闭合装置市场

  • 介绍
  • 市场概览
  • 市场分析与预测
    • 冠状动脉封堵器市场整体状况
    • 竞争激烈的VCD市场
    • 非侵入式VCD市场
  • 驾驶员和约束装置
  • 竞争市占率分析

诊断性冠状动脉导管和导管导引线市场

  • 介绍
  • 市场概览
  • 市场分析与预测
    • 冠状动脉诊断导管和导管导引线市场总规模
    • 诊断导管市场
    • 诊断导管导引线市场
    • 血流储备分数导管导引线市场
  • 驾驶员和约束装置
  • 竞争市占率分析

冠状动脉血管内超音波市场

  • 介绍
    • 支架置入前
    • 支架置入术后
    • 静脉注射
  • 市场概览
  • 市场分析与预测
    • Ivus导管市场
    • Ivus主机市场
  • 驾驶员和约束装置
  • 竞争市占率分析

冠状动脉光学同调断层扫描市场

  • 介绍
  • 市场概览
  • 市场分析与预测
    • OCT导管市场
    • OCT主机市场
  • 驾驶员和约束装置
  • 竞争市占率分析

止血阀市场

  • 介绍
  • 市场分析与预测
  • 驾驶员和约束装置
  • 竞争市占率分析

简称

Product Code: iDATA_USIC25_MS

The U.S. interventional cardiology device market was valued at nearly $4.4 billion in 2024. The market is projected to exceed $5.6 billion over the forecast period.

This report sizes and analyzes all core product categories used in percutaneous coronary intervention and related diagnostic workups, including coronary stents, coronary balloon catheters, balloon-inflation devices, interventional coronary catheters, interventional coronary guidewires, coronary embolic protection devices (EPDs), coronary atherectomy and intravascular lithotripsy (IVL) devices, coronary thrombectomy, coronary chronic total occlusion (CTO) systems, introducer sheaths, coronary vascular closure devices (VCDs), diagnostic coronary catheters and guidewires, coronary intravascular ultrasound (IVUS), coronary optical coherence tomography (OCT), and hemostasis valves.

Quantitative coverage includes unit sales, average selling prices, market values, growth rates, company shares, and procedure numbers.

Qualitative coverage includes market drivers and limiters, mergers and acquisitions, portfolio updates, and practical technology trends across hospitals and cath labs.

Market Overview

Interventional cardiology in the United States continues to evolve toward data-guided, image-rich, and workflow-efficient procedures. PCI volumes are expected to rise at a low single-digit rate, but device demand is shaped more by product mix than by raw volume alone.

Physicians use IVUS and OCT to size vessels, characterize plaque, and optimize stent expansion. This imaging-first approach influences selection of PTCA and specialty balloons, drug-eluting stents, and lesion preparation tools including atherectomy and IVL for calcified disease. At the same time, facilities face staffing constraints, price pressure, and contract consolidation.

These forces drive interest in bundled contracts, standardized trays, radial access, and closure devices that shorten recovery and turn rooms faster.

Over the forecast period, imaging will be more deeply integrated into planning and decision making, while stent and balloon platforms will continue to improve deliverability, profiles, and coating technologies to serve a broader range of lesions with predictable outcomes.

Market Drivers

New technological developments. Adoption of advanced cardiovascular imaging, including CT, MRI, IVUS, and OCT, improves lesion detection and procedural planning. Next-generation drug-eluting stents with refined construction and thinner drug coatings are expected to enhance effectiveness and broaden treatable lesion types.

High rate of research and development. A growing patient population attracts more participants across segments. Competition accelerates innovation in guidewires, micro-catheters, balloons, atherectomy, IVL, and closure devices, leading to faster and less invasive procedures with more consistent results.

Rising rates of diabetes. In 2021, about 11 percent of the U.S. population had diabetes. This disease burden raises the prevalence of coronary artery disease and supports steady PCI demand, particularly in complex lesions associated with diffuse atherosclerosis and calcification.

PCI procedure volume. PCI is projected to grow at a low single-digit rate. Even modest procedural expansion increases demand for stents, balloon catheters, interventional catheters, guidewires, and associated equipment used in each case.

Imaging-led optimization. Facilities invest in IVUS consoles, OCT platforms, and imaging catheters to reduce geographic miss, optimize stent expansion, and document results for quality programs and payers.

Radial access and recovery. Wider use of radial access supports patient comfort and shorter stays. This favors micro-introducers, radial-specific sheaths, and closure devices tailored to rapid hemostasis and early ambulation.

Lesion preparation tools. Complex calcified lesions drive use of atherectomy and IVL to improve deliverability and ensure full stent expansion, which reduces restenosis risk and repeat procedures.

Market Limiters

External market shortages. Skilled labor shortages affect both suppliers and providers. Production delays, longer service cycles, and staffing gaps in cath labs slow throughput and weight capital planning. These pressures also push the market toward automation and streamlined product choices.

Bundling and price pressure. Large competitors use broad portfolios to negotiate system-wide contracts covering stents, balloons, guidewires, catheters, and VCDs. Bundling simplifies procurement but compresses ASPs and challenges smaller manufacturers. As consolidation continues, steady price declines are expected in many categories.

Alternative treatment methods for CAD. Beyond PCI, patients and clinicians use rehab programs, medical therapy optimization, and personal self-management. Complementary and alternative approaches, self-testing, and drug advances can delay or substitute for interventions in some cases, dampening procedural growth.

Capital diligence for imaging. OCT and IVUS require upfront console investment and ongoing disposable costs. Some centers phase adoption while they evaluate utilization and reimbursement patterns.

Supply chain and regulatory friction. Portfolio refreshes and compliance steps can lengthen launch timelines and complicate inventory.

Market Coverage and Data Scope

Quantitative coverage. Market size, market shares, market forecasts, growth rates, units sold, average selling prices, and procedure numbers.

Qualitative coverage. Growth drivers and limiters, competitive analysis and SWOT for top competitors, mergers and acquisitions, company profiles and product portfolios, FDA recalls where applicable, disruptive technologies, and disease overviews that influence PCI care pathways.

Time frame. Base year 2024, forecasts 2025 to 2031, historical data 2021 to 2024.

Data sources. Primary interviews with industry leaders and physicians, government physician and procedure data, regulatory databases, hospital private data, import and export data, and the iData Research internal database.

Method note. Revenue is modeled from units multiplied by ASP and validated against PCI volumes, imaging adoption, access approach mix, and facility purchasing patterns across hospitals and integrated delivery networks.

Markets Covered and Segmentation

Coronary Stent Market

Device type. Bare-metal stent, drug-eluting stent, covered stent, bifurcated stent.

Single-year unit share breakdown by size. Diameter and length.

Coronary Balloon Catheter

Device type. PTCA balloon and specialty balloon.

Single-year unit share by classification. Compliant, semi-compliant, non-compliant.

Single-year unit share by indication. Pre-dilation and stent placement, post-dilation.

Balloon-Inflation Device

Interventional Coronary Catheter

Device type. Guiding catheter, extension guide catheter, micro-catheter.

Interventional Coronary Guidewire

Coronary Embolic Protection Device (EPD)

Coronary Atherectomy Device

Device type. Mechanical atherectomy, laser atherectomy, intravascular lithotripsy (IVL).

Coronary Thrombectomy

Coronary Chronic Total Occlusion (CTO) System

Device type. CTO guidewire, CTO catheter, CTO device.

Introducer Sheath

Device type. Standard introducer, micro-introducer.

By approach. Femoral, radial.

Coronary Vascular Closure Device (VCD)

Invasive VCD and non-invasive VCD.

Diagnostic Coronary Catheter and Guidewire

Device type. Diagnostic catheter, diagnostic guidewire, fractional flow reserve guidewire.

Coronary Intravascular Ultrasound (IVUS)

Device type. IVUS catheter, IVUS console.

Coronary Optical Coherence Tomography (OCT)

Device type. OCT catheter, OCT console.

Hemostasis Valve

Competitive Analysis

Boston Scientific was the leading competitor in 2024 with dominant positions in coronary stents, coronary balloon catheters, and coronary embolic protection devices. A new coronary drug-coated balloon is expected to support modest share expansion as adoption develops.

Abbott ranked second with a broad portfolio and frequent top positions across device categories. Abbott faces no direct competition in the OCT segment, which supports its standing across imaging-driven PCI strategies. The company is expected to maintain overall share.

ShockWave Medical ranked third and specializes in intravascular lithotripsy (IVL). IVL has been approved only in recent years but continues to expand quickly due to its ability to address calcified plaque in coronary vessels.

Other participants compete in selected stents, balloons, guidewires, catheters, VCDs, thrombectomy, and imaging. Competitive advantage reflects portfolio depth, radial access solutions, deliverability in tortuous anatomy, and the ability to tie imaging guidance to lesion preparation and device deployment.

Technology and Practice Trends

Imaging becomes procedural fabric. IVUS and OCT move from optional tools to routine guidance in many labs. Physicians rely on imaging to assess plaque morphology, calcification depth, and stent expansion. High-resolution CT supports pre-procedural planning in selected cases.

Calcium management. Growth in atherectomy and IVL reflects the need to treat heavily calcified lesions safely and predictably. These tools increase the likelihood of full stent expansion and durable outcomes.

Smarter balloons and stents. Specialty balloons with defined compliance and improved profiles, along with refined drug-eluting stents, help address complex anatomies and bifurcations while keeping procedure time under control.

Radial-first workflow. Facilities invest in radial introducers, micro-introducers, and closure solutions that support early ambulation and same-day discharge in appropriate patients.

Room efficiency. Staffing shortages push labs to standardize trays, streamline inflation devices, and select closure devices that reduce recovery time. Imaging-driven optimization also reduces repeat procedures and supports value-based targets.

Data and documentation. Imaging systems and consoles support case documentation for quality programs, peer review, and contracting, which strengthens the capital case for adoption.

Care Settings

Coverage includes hospitals, integrated delivery networks, and cath labs in academic and community settings. The report addresses procurement models that use direct purchase and group purchasing contracts, along with vendor-managed inventory where used.

Facility type influences access approach, imaging adoption, and preferences for bundled contracts.

Radial-first centers emphasize micro-introducers and closure products.

High-volume centers with complex case mix tend to invest earlier in IVUS and OCT and carry a wider range of atherectomy and IVL tools for calcium management.

Geography

This edition covers the United States.

Why This Report

Where is the largest and fastest growing opportunity within the U.S. interventional cardiology device market and how do stents, balloons, atherectomy, IVL, CTO systems, guidewires, catheters, EPDs, VCDs, IVUS, and OCT each contribute to value through 2031.

How does the interventional cardiology device market relate to the broader U.S. economy and hospital operations, including staffing constraints, capital planning for imaging, and purchasing strategies that favor bundles and standardization.

What forces will shape the market going forward, including growth in IVUS and OCT, refinement of drug-eluting stents, and the spread of radial access and same-day discharge pathways.

Which imaging modalities best support optimization in daily practice, and how should labs decide between IVUS and OCT based on case mix, reimbursement, and staff proficiency.

How will lesion preparation strategies evolve, and what is the right role for atherectomy versus IVL when treating severe calcification to ensure full expansion and reduce restenosis.

What mix of balloons is most effective across pre-dilation and post-dilation, and how do compliant, semi-compliant, and non-compliant profiles affect deliverability, safety, and consistency.

What is the expected balance between radial and femoral access, and how will this choice change demand for introducer sheaths, micro-introducers, closure devices, hemostasis valves, and accessory kits across hospitals and cath labs.

How will imaging choices evolve, in particular the adoption of OCT versus IVUS for lesion assessment, stent sizing, and post-deployment optimization, and what does this mean for console placements, disposable catheter pull-through, and training needs.

How will the next generation of drug-eluting stents and drug-coated balloons affect case selection and pricing, given the history of safety reviews and the emphasis on thinner struts, polymer changes, and controlled drug delivery.

What is the realistic trajectory for intravascular lithotripsy in calcified lesions, and how will IVL usage interact with atherectomy and high-pressure non-compliant balloons in complex PCI.

The U.S. interventional cardiology device market report from iData Research answers these questions with segment and setting models, company share analysis, pricing detail, and coverage that links imaging and access choices to device consumption.

Use it to size opportunities by category, plan product roadmaps, align contracting and inventory with hospital needs, and set targets for training and service that improve consistency across cath labs.

TABLE OF CONTENT

Table Of Contents

List Of Figures

List Of Charts

U.S. Interventional Cardiology Device Market Overview

Competitive Analysis

Market Developments

Market Trends

Procedure Segmentation

Procedure Codes Investigated

Market Segmentation

Key Report Updates

Version History

Research Methodology

  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems And Perform Secondary Research
  • Step 3: Preparation For Interviews & Questionnaire Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecast And Analysis
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review And Market Release
  • Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

U.S. Interventional Cardiology Device Market Overview

  • 3.1 Introduction
    • 3.1.1 Population At Risk
  • 3.2 Market Overview & Trend Analysis
  • 3.3 Drivers And Limiters
    • 3.3.1 Market Drivers
    • 3.3.2 Market Limiters
  • 3.4 Competitive Market Share Analysis
  • 3.5 Mergers And Acquisitions

Procedure Numbers

  • 4.1 Introduction
  • 4.2 Procedures
    • 4.2.1 Angiography Procedures
    • 4.2.2 Angioplasty/ Pci Procedures
    • 4.2.3 Coronary Atherectomy Procedures
    • 4.2.4 Coronary Chronic Total Occlusion Procedures
    • 4.2.5 Catheterization Procedures
    • 4.2.6 Coronary Intravascular Ultrasound Procedures
    • 4.2.7 Coronary Optical Coherence Tomography Procedures
    • 4.2.8 Fractional Flow Reserve Guidewire Procedures

Coronary Stent Market

  • 5.1 Introduction
  • 5.2 Market Overview
  • 5.3 Market Analysis And Forecast
    • 5.3.1 Total Coronary Stent Market
    • 5.3.2 Bare-Metal Stent Market
    • 5.3.3 Drug-Eluting Stent Market
    • 5.3.4 Covered Stent Market
    • 5.3.5 Bifurcated Stent Market
  • 5.4 Unit Analysis
    • 5.4.1 Coronary Stent Units Sold By Diameter
    • 5.4.2 Coronary Stent Units Sold By Length
  • 5.5 Drivers And Limiters
    • 5.5.1 Market Drivers
    • 5.5.2 Market Limiters
  • 5.6 Competitive Market Share Analysis

Coronary Balloon Catheter Market

  • 6.1 Introduction
  • 6.2 Market Overview
  • 6.3 Market Analysis And Forecast
    • 6.3.1 Total Coronary Balloon Catheter Market
    • 6.3.2 Ptca Balloon Market
    • 6.3.3 Specialty Balloon Market
      • 6.3.3.1 Cutting Balloon Market
      • 6.3.3.2 Scoring Balloon Market
      • 6.3.3.3 Drug-Coated Balloon Market
    • 6.3.4 Coronary Balloon Catheter Units By Classification
    • 6.3.5 Coronary Balloon Catheter Units By Indication
  • 6.4 Drivers And Limiters
    • 6.4.1 Market Drivers
    • 6.4.2 Market Limiters
  • 6.5 Competitive Market Share Analysis

Balloon-Inflation Device Market

  • 7.1 Introduction
  • 7.2 Market Analysis And Forecast
  • 7.3 Drivers And Limiters
    • 7.3.1 Market Drivers
    • 7.3.2 Market Limiters
  • 7.4 Competitive Market Share Analysis

Interventional Coronary Catheter Market

  • 8.1 Introduction
  • 8.2 Market Overview
  • 8.3 Market Analysis And Forecast
    • 8.3.1 Total Interventional Coronary Catheter Market
    • 8.3.2 Guiding Catheter Market
    • 8.3.3 Extension Guide Catheter Market
    • 8.3.4 Micro-Catheter Market
      • 8.3.4.1 Traditional Coronary Microcatheter Market
      • 8.3.4.1.1 Torqueable Traditional Coronary Microcatheter Market
      • 8.3.4.1.2 Braided Traditional Coronary Microcatheter Market
      • 8.3.4.2 Dual Lumen Specialty Coronary Microcatheter Market
  • 8.4 Drivers And Limiters
    • 8.4.1 Market Drivers
    • 8.4.2 Market Limiters
  • 8.5 Competitive Market Share Analysis

Interventional Coronary Guidewire Market

  • 9.1 Introduction
    • 9.1.1 Device Construction
  • 9.2 Market Analysis And Forecast
  • 9.3 Drivers And Limiters
    • 9.3.1 Market Drivers
    • 9.3.2 Market Limiters
  • 9.4 Competitive Market Share Analysis

Coronary Embolic Protection Device Market

  • 10.1 Introduction
    • 10.1.1 Saphenous Vein Grafts
    • 10.1.2 Protection Mechanism
      • 10.1.2.1 Filter Basket
      • 10.1.2.2 Distal Balloon Occlusion
  • 10.2 Market Analysis And Forecast
  • 10.3 Drivers And Limiters
    • 10.3.1 Market Drivers
    • 10.3.2 Market Limiters
  • 10.4 Competitive Market Share Analysis

Coronary Atherectomy Device Market

  • 11.1 Introduction
    • 11.1.1 Device Technologies
      • 11.1.1.1 Mechanical Atherectomy
      • 11.1.1.2 Laser Atherectomy
      • 11.1.1.3 Directional Coronary Atherectomy (Dca)
      • 11.1.1.4 Intravascular Lithotripsy
  • 11.2 Market Overview
  • 11.3 Market Analysis And Forecast
    • 11.3.1 Total Coronary Atherectomy Device Market
    • 11.3.2 Mechanical Atherectomy Market
    • 11.3.3 Laser Atherectomy Market
    • 11.3.4 Intravascular Lithotripsy Market
  • 11.4 Drivers And Limiters
    • 11.4.1 Market Drivers
    • 11.4.2 Market Limiters
  • 11.5 Competitive Market Share Analysis

Coronary Thrombectomy Market

  • 12.1 Introduction
    • 12.1.1 Drug-Eluting Stents And Thrombosis Treatment
  • 12.2 Market Analysis And Forecast
  • 12.3 Drivers And Limiters
    • 12.3.1 Market Drivers
    • 12.3.2 Market Limiters
  • 12.4 Competitive Market Share Analysis

Coronary Chronic Total Occlusion System Market

  • 13.1 Introduction
  • 13.2 Market Overview
  • 13.3 Market Analysis And Forecast
    • 13.3.1 Total Coronary Chronic Total Occlusion System Market
    • 13.3.2 Cto Guidewire Market
    • 13.3.3 Cto Catheter Market
    • 13.3.4 Cto Device Market
  • 13.4 Drivers And Limiters
    • 13.4.1 Market Drivers
    • 13.4.2 Market Limiters
  • 13.5 Competitive Market Share Analysis

Introducer Sheath Market

  • 14.1 Introduction
  • 14.2 Market Overview
  • 14.3 Market Analysis And Forecast
    • 14.3.1 Total Introducer Sheath Market
    • 14.3.2 Standard Introducer Sheath Market
    • 14.3.3 Micro-Introducer Sheath Market
  • 14.4 Introducer Sheath Units By Approach
  • 14.5 Drivers And Limiters
    • 14.5.1 Market Drivers
    • 14.5.2 Market Limiters
  • 14.6 Competitive Market Share Analysis

Coronary Vascular Closure Device Market

  • 15.1 Introduction
  • 15.2 Market Overview
  • 15.3 Market Analysis And Forecast
    • 15.3.1 Total Coronary Vascular Closure Device Market
    • 15.3.2 Invasive Vcd Market
    • 15.3.3 Non-Invasive Vcd Market
      • 15.3.3.1 Topical Hemostat Market
      • 15.3.3.2 Radial Compression Band Market
      • 15.3.3.3 Femoral Compression Band Market
  • 15.4 Drivers And Limiters
    • 15.4.1 Market Drivers
    • 15.4.2 Market Limiters
  • 15.5 Competitive Market Share Analysis

Diagnostic Coronary Catheter & Guidewire Market

  • 16.1 Introduction
  • 16.2 Market Overview
  • 16.3 Market Analysis And Forecast
    • 16.3.1 Total Diagnostic Coronary Catheter & Guidewire Market
    • 16.3.2 Diagnostic Catheter Market
    • 16.3.3 Diagnostic Guidewire Market
    • 16.3.4 Fractional Flow Reserve Guidewire Market
  • 16.4 Drivers And Limiters
    • 16.4.1 Market Drivers
    • 16.4.2 Market Limiters
  • 16.5 Competitive Market Share Analysis

Coronary Intravascular Ultrasound Market

  • 17.1 Introduction
    • 17.1.1 Pre-Stenting Applications
    • 17.1.2 Post-Stenting Applications
    • 17.1.3 Ivus Penetration
  • 17.2 Market Overview
  • 17.3 Market Analysis And Forecast
    • 17.3.1 Ivus Catheter Market
    • 17.3.2 Ivus Console Market
  • 17.4 Drivers And Limiters
    • 17.4.1 Market Drivers
    • 17.4.2 Market Limiters
  • 17.5 Competitive Market Share Analysis

Coronary Optical Coherency Tomography Market

  • 18.1 Introduction
  • 18.2 Market Overview
  • 18.3 Market Analysis And Forecast
    • 18.3.1 Oct Catheter Market
    • 18.3.2 Oct Console Market
  • 18.4 Drivers And Limiters
    • 18.4.1 Market Drivers
    • 18.4.2 Market Limiters
  • 18.5 Competitive Market Share Analysis

Hemostasis Valve Market

  • 19.1 Introduction
  • 19.2 Market Analysis And Forecast
  • 19.3 Drivers And Limiters
    • 19.3.1 Market Drivers
    • 19.3.2 Market Limiters
  • 19.4 Competitive Market Share Analysis

Abbreviations

LIST OF CHARTS

  • Chart 1-1: Interventional Cardiology Device Market by Segment, U.S., 2024 - 2031. 2
  • Chart 1-2: Interventional Cardiology Device Market Overview, U.S., 2024 & 2031. 2
  • Chart 3-1: Interventional Cardiology Device Market by Segment, U.S., 2021 - 2031. 42
  • Chart 3-2: Leading Competitors, Interventional Cardiology Device Market, U.S., 2024. 53
  • Chart 4-1: Interventional Cardiology Procedures by Segment, U.S., 2021 - 2031. 59
  • Chart 5-1: Coronary Stent Market by Segment, U.S., 2021 - 2031. 78
  • Chart 5-2: Leading Competitors, Coronary Stent Market, U.S., 2024. 91
  • Chart 6-1: Coronary Balloon Catheter Market by Segment, U.S., 2021 - 2031. 95
  • Chart 6-2: Leading Competitors, Coronary Balloon Catheter Market, U.S., 2024. 110
  • Chart 7-1: Balloon-Inflation Device Market, U.S., 2021 - 2031. 113
  • Chart 7-2: Leading Competitors, Balloon-Inflation Device Market, U.S., 2024. 119
  • Chart 8-1: Interventional Coronary Catheter Market by Segment, U.S., 2021 - 2031. 122
  • Chart 8-2: Leading Competitors, Interventional Coronary Catheter Market, U.S., 2024. 138
  • Chart 9-1: Interventional Coronary Guidewire Market, U.S., 2021 - 2031. 141
  • Chart 9-2: Leading Competitors, Interventional Coronary Guidewire Market, U.S., 2024. 147
  • Chart 10-1: Coronary Embolic Protection Device Market, U.S., 2021 - 2031. 151
  • Chart 10-2: Leading Competitors, Coronary Embolic Protection Device Market, U.S., 2024. 156
  • Chart 11-1: Coronary Atherectomy Device Market by Segment, U.S., 2021 - 2031. 160
  • Chart 11-2: Leading Competitors, Coronary Atherectomy Device Market, U.S., 2024. 169
  • Chart 12-1: Coronary Thrombectomy Market, U.S., 2021 - 2031. 173
  • Chart 12-2: Leading Competitors, Coronary Thrombectomy Market, U.S., 2024. 178
  • Chart 13-1: Coronary Chronic Total Occlusion System Market by Segment, U.S., 2021 - 2031. 182
  • Chart 13-2: Leading Competitors, Coronary Chronic Total Occlusion System Market, U.S., 2024. 191
  • Chart 14-1: Introducer Sheath Market by Segment, U.S., 2021 - 2031. 194
  • Chart 14-2: Leading Competitors, Introducer Sheath Market, U.S., 2024. 205
  • Chart 15-1: Coronary Vascular Closure Device Market by Segment, U.S., 2021 - 2031. 209
  • Chart 15-2: Leading Competitors, Coronary Vascular Closure Device Market, U.S., 2024. 223
  • Chart 16-1: Diagnostic Coronary Catheter & Guidewire Market by Segment, U.S., 2021 - 2031. 226
  • Chart 16-2: Leading Competitors, Diagnostic Coronary Catheter & Guidewire Market, U.S., 2024. 236
  • Chart 17-1: Coronary Intravascular Ultrasound Market by Segment, U.S., 2021 - 2031. 240
  • Chart 17-2: Leading Competitors, Coronary Intravascular Ultrasound Market, U.S., 2024. 248
  • Chart 18-1: Coronary Optical Coherency Tomography Market by Segment, U.S., 2021 - 2031. 252
  • Chart 18-2: Leading Competitors, Coronary Optical Coherency Tomography Market, U.S., 2024. 260
  • Chart 19-1: Hemostasis Valve Market, U.S., 2021 - 2031. 263
  • Chart 19-2: Leading Competitors, Hemostasis Valve Market, U.S., 2024 268

LIST OF FIGURES

  • Figure 1-1: Interventional Cardiology Device Market Share Ranking by Segment, U.S., 2024 (1 of 3). 3
  • Figure 1-2: Interventional Cardiology Device Market Share Ranking by Segment, U.S., 2024 (2 of 3). 4
  • Figure 1-3: Interventional Cardiology Device Market Share Ranking by Segment, U.S., 2024 (3 of 3). 4
  • Figure 1-4: Companies Researched in This Report. 5
  • Figure 1-5: Recent Events in the Interventional Cardiology Device Market, U.S., 2021 - 2025 (1 of 2). 7
  • Figure 1-6: Recent Events in the Interventional Cardiology Device Market, U.S., 2021 - 2025 (2 of 2). 8
  • Figure 1-7: Factors Impacting the Interventional Cardiology Device Market by Segment, U.S. (1 of 3). 9
  • Figure 1-8: Factors Impacting the Interventional Cardiology Device Market by Segment, U.S. (2 of 3). 10
  • Figure 1-9: Factors Impacting the Interventional Cardiology Device Market by Segment, U.S. (3 of 3). 11
  • Figure 1-10: Interventional Cardiology Device Procedure Segmentation (1 of 2). 12
  • Figure 1-11: Interventional Cardiology Device Procedure Segmentation (2 of 2). 13
  • Figure 1-12: Procedure Codes Investigated. 14
  • Figure 1-13: Interventional Cardiology Device Market Segmentation (1 of 3). 15
  • Figure 1-14: Interventional Cardiology Device Market Segmentation (2 of 3). 16
  • Figure 1-15: Interventional Cardiology Device Market Segmentation (3 of 3). 17
  • Figure 1-16: Key Report Updates. 18
  • Figure 1-17: Version History. 19
  • Figure 3-1: Interventional Cardiology Device Market by Segment, U.S., 2021 - 2031 (US$M) (1 of 3). 39
  • Figure 3-2: Interventional Cardiology Device Market by Segment, U.S., 2021 - 2031 (US$M) (2 of 3). 40
  • Figure 3-3: Interventional Cardiology Device Market by Segment, U.S., 2021 - 2031 (US$M) (3 of 3). 41
  • Figure 3-4: Leading Competitors, Interventional Cardiology Device Market, U.S., 2024 (1 of 3). 50
  • Figure 3-5: Leading Competitors, Interventional Cardiology Device Market, U.S., 2024 (2 of 3). 51
  • Figure 3-6: Leading Competitors, Interventional Cardiology Device Market, U.S., 2024 (3 of 3). 52
  • Figure 4-1: Procedure Codes Investigated, U.S., 2024. 56
  • Figure 4-2: Interventional Cardiology Device Procedures by Segment, U.S., 2021 - 2031 (1 of 2). 57
  • Figure 4-3: Interventional Cardiology Device Procedures by Segment, U.S., 2021 - 2031 (2 of 2). 58
  • Figure 4-4: Angiography Procedures by Devices Used, U.S., 2021 - 2031. 60
  • Figure 4-5: Angiography Procedures by Approach, U.S., 2021 - 2031. 61
  • Figure 4-6: Angiography Procedures by Setting, U.S., 2021 - 2031. 61
  • Figure 4-7: Angioplasty Procedures by Approach, U.S., 2021 - 2031. 62
  • Figure 4-8: Angioplasty Procedures by Modality, U.S., 2021 - 2031. 63
  • Figure 4-9: Angioplasty Procedures by Setting, U.S., 2021 - 2031. 63
  • Figure 4-10: Atherectomy Procedures by Segment, U.S., 2021 - 2031. 65
  • Figure 4-11: Atherectomy Procedures by Setting, U.S., 2021 - 2031. 66
  • Figure 4-12: CTO Procedures by Setting, U.S., 2021 - 2031. 68
  • Figure 4-13: Catheterization Procedures by Setting, U.S., 2021 - 2031. 70
  • Figure 4-14: IVUS Procedures by Segment, U.S., 2021 - 2031. 71
  • Figure 4-15: OCT Procedures by Segment, U.S., 2021 - 2031. 72
  • Figure 4-16: FFR Procedures by Segment, U.S., 2021 - 2031. 73
  • Figure 5-1: Coronary Market by Segment, U.S., 2021 - 2031 (US$M). 77
  • Figure 5-2: Total Coronary Stent Market, U.S., 2021 - 2031. 79
  • Figure 5-3: Bare-Metal Stent Market, U.S., 2021 - 2031. 80
  • Figure 5-4: Drug-Eluting Stent Market, U.S., 2021 - 2031. 81
  • Figure 5-5: Covered Stent Market, U.S., 2021 - 2031. 82
  • Figure 5-6: Bifurcated Stent Market, U.S., 2021 - 2031. 83
  • Figure 5-7: Percent of Coronary Stent Units Sold by Diameter, U.S., 2024. 84
  • Figure 5-8: Percent of Coronary Stent Units Sold by Diameter, U.S., 2024. 85
  • Figure 5-9: Leading Competitors, Coronary Stent Market, U.S., 2024. 90
  • Figure 6-1: Coronary Balloon Catheter Market by Segment, U.S., 2021 - 2031 (US$M). 94
  • Figure 6-2: Total Coronary Balloon Catheter Market, U.S., 2021 - 2031. 96
  • Figure 6-3: PTCA Balloon Market, U.S., 2021 - 2031. 97
  • Figure 6-4: Specialty Balloon Market by Segment, U.S., 2021 - 2031 (US$M). 99
  • Figure 6-5: Total Specialty Balloon Catheter Market, U.S., 2021 - 2031. 99
  • Figure 6-6: Cutting Balloon Market, U.S., 2021 - 2031. 100
  • Figure 6-7: Scoring Balloon Market, U.S., 2021 - 2031. 101
  • Figure 6-8: Drug-Coated Balloon Market, U.S., 2021 - 2031. 102
  • Figure 6-9: Coronary Balloon Catheter Units by Classification, U.S., 2024. 103
  • Figure 6-10: Coronary Balloon Catheter Units by Classification, U.S., 2024. 104
  • Figure 6-11: Leading Competitors, Coronary Balloon Catheter Market, U.S., 2024. 109
  • Figure 7-1: Balloon-Inflation Device Market, U.S., 2021 - 2031. 112
  • Figure 7-2: Leading Competitors, Balloon-Inflation Device Market, U.S., 2024. 118
  • Figure 8-1: Interventional Coronary Catheter Market by Segment, U.S., 2021 - 2031 (US$M). 121
  • Figure 8-2: Total Interventional Coronary Catheter Market, U.S., 2021 - 2031. 123
  • Figure 8-3: Guiding Catheter Market, U.S., 2021 - 2031. 124
  • Figure 8-4: Extension Guide Catheter Market, U.S., 2021 - 2031. 125
  • Figure 8-5: Micro-Catheter Market by Segment, U.S., 2021 - 2031 (US$M). 126
  • Figure 8-6: Total Micro-Catheter Market, U.S., 2021 - 2031. 127
  • Figure 8-7: Traditional Coronary Microcatheter Market by Segment, U.S., 2021 - 2031 (US$M). 128
  • Figure 8-8: Total Traditional Coronary Microcatheter Market, U.S., 2021 - 2031. 129
  • Figure 8-9: Torqueable Traditional Coronary Microcatheter Market, U.S., 2021 - 2031. 130
  • Figure 8-10: Braided Traditional Coronary Microcatheter Market, U.S., 2021 - 2031. 131
  • Figure 8-11: Dual Lumen Specialty Coronary Microcatheter Market, U.S., 2021 - 2031. 132
  • Figure 8-12: Leading Competitors, Interventional Coronary Catheter Market, U.S., 2024. 137
  • Figure 9-1: Interventional Coronary Guidewire Market, U.S., 2021 - 2031. 140
  • Figure 9-2: Leading Competitors, Interventional Coronary Guidewire Market, U.S., 2024. 146
  • Figure 10-1: Coronary Embolic Protection Device Market, U.S., 2021 - 2031. 150
  • Figure 10-2: Leading Competitors, Coronary Embolic Protection Device Market, U.S., 2024. 155
  • Figure 11-1: Coronary Atherectomy Device Market by Segment, U.S., 2021 - 2031 (US$M). 159
  • Figure 11-2: Total Coronary Atherectomy Device Market, U.S., 2021 - 2031. 161
  • Figure 11-3: Mechanical Atherectomy Market, U.S., 2021 - 2031. 162
  • Figure 11-4: Laser Atherectomy Market, U.S., 2021 - 2031. 163
  • Figure 11-5: Intravascular Lithotripsy Market, U.S., 2021 - 2031. 164
  • Figure 11-6: Leading Competitors, Coronary Atherectomy Device Market, U.S., 2024. 168
  • Figure 12-1: Coronary Thrombectomy Market, U.S., 2021 - 2031. 172
  • Figure 12-2: Leading Competitors, Coronary Thrombectomy Market, U.S., 2024. 177
  • Figure 13-1: Coronary Chronic Total Occlusion System Market by Segment, U.S., 2021 - 2031 (US$M). 181
  • Figure 13-2: Total Coronary Chronic Total Occlusion System Market, U.S., 2021 - 2031. 183
  • Figure 13-3: CTO Guidewire Market, U.S., 2021 - 2031. 184
  • Figure 13-4: CTO Catheter Market, U.S., 2021 - 2031. 185
  • Figure 13-5: CTO Device Market, U.S., 2021 - 2031. 186
  • Figure 13-6: Leading Competitors, Coronary Chronic Total Occlusion System Market, U.S., 2024. 190
  • Figure 14-1: Introducer Sheath Market by Segment, U.S., 2021 - 2031 (US$M). 193
  • Figure 14-2: Total Introducer Sheath Market, U.S., 2021 - 2031. 195
  • Figure 14-3: Standard Introducer Sheath Market, U.S., 2021 - 2031. 196
  • Figure 14-4: Micro-Introducer Sheath Market, U.S., 2021 - 2031. 197
  • Figure 14-5: Introducer Sheath Units, by Approach, U.S., 2021 - 2031. 198
  • Figure 14-6: Leading Competitors, Introducer Sheath Market, U.S., 2024. 204
  • Figure 15-1: Coronary Vascular Closure Device Market by Segment, U.S., 2021 - 2031 (US$M). 208
  • Figure 15-2: Total Coronary Vascular Closure Device Market, U.S., 2021 - 2031. 211
  • Figure 15-3: Invasive VCD Market, U.S., 2021 - 2031. 212
  • Figure 15-4: Non-Invasive VCD Market by Segment, U.S., 2021 - 2031 (US$M). 213
  • Figure 15-5: Total Non-Invasive VCD Market, U.S., 2021 - 2031. 214
  • Figure 15-6: Topical Hemostat Market, U.S., 2021 - 2031. 215
  • Figure 15-7: Radial Compression Band Market, U.S., 2021 - 2031. 216
  • Figure 15-8: Femoral Compression Band Market, U.S., 2021 - 2031. 217
  • Figure 15-9: Leading Competitors, Coronary Vascular Closure Device Market, U.S., 2024. 222
  • Figure 16-1: Diagnostic Coronary Catheter & Guidewire Market by Segment, U.S., 2021 - 2031 (US$M). 225
  • Figure 16-2: Total Diagnostic Coronary Catheter & Guidewire Market, U.S., 2021 - 2031. 227
  • Figure 16-3: Diagnostic Catheter Market, U.S., 2021 - 2031. 228
  • Figure 16-4: Diagnostic Guidewire Market, U.S., 2021 - 2031. 229
  • Figure 16-5: Fractional Flow Reserve Guidewire Market, U.S., 2021 - 2031. 230
  • Figure 16-6: Leading Competitors, Diagnostic Coronary Catheter & Guidewire Market, U.S., 2024. 235
  • Figure 17-1: Coronary Intravascular Ultrasound Market by Segment, U.S., 2021 - 2031 (US$M). 239
  • Figure 17-2: IVUS Catheter Market, U.S., 2021 - 2031. 242
  • Figure 17-3: IVUS Console Market, U.S., 2021 - 2031. 243
  • Figure 17-4: Leading Competitors, Coronary Intravascular Ultrasound Market, U.S., 2024. 247
  • Figure 18-1: Coronary Optical Coherency Tomography Market by Segment, U.S., 2021 - 2031 (US$M). 251
  • Figure 18-2: OCT Catheter Market, U.S., 2021 - 2031. 253
  • Figure 18-3: OCT Console Market, U.S., 2021 - 2031. 254
  • Figure 18-4: Leading Competitors, Coronary Optical Coherency Tomography Market, U.S., 2024. 259
  • Figure 19-1: Hemostasis Valve Market, U.S., 2021 - 2031. 262
  • Figure 19-2: Leading Competitors, Hemostasis Valve Market, U.S., 2024. 267